Bortezomib Terminated Phase 2 Trials for Recurrent Grade 3 Follicular Lymphoma / Recurrent Mantle Cell Lymphoma / Recurrent Adult Diffuse Large Cell Lymphoma / Recurrent Grade 2 Follicular Lymphoma / Recurrent Grade 1 Follicular Lymphoma Treatment